Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 14/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30782338 | 0.81 | TNF (0.46) | DRD2SIGMAR1DRD3POLBMEN1 | |
| SCHEMBL31607726 | 0.80 | TNF (0.39) | DRD2POLBMEN1KMT2A | |
| SCHEMBL976417 | 0.80 | ADORA1 (0.48) | POLBMEN1TP53KMT2A | |
| SCHEMBL31607756 | 0.80 | DRD2 (0.41) | DRD2SIGMAR1DRD3CACNA1HMEN1 | |
| SCHEMBL27139330 | 0.79 | HDAC6 (0.42) | DRD2SIGMAR1DRD3POLBMEN1 | |
| SCHEMBL12922709 | 0.76 | KDM4E (0.43) | POLBMEN1ALOX15KMT2A | |
| SCHEMBL30945677 | 0.74 | DRD2 (0.65) | DRD2SIGMAR1POLBMEN1TP53 | |
| Hydrochloric Acid SCHEMBL11184859 | 0.74 | CHRM2 (0.39) | POLBMEN1ALOX15KMT2A | |
| SCHEMBL27140818 | 0.73 | DRD2 (0.44) | DRD2SIGMAR1CACNA1HMEN1KMT2A | |
| SCHEMBL978771 | 0.73 | ADORA1 (0.48) | POLBMEN1TP53KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120091998-A | Substituted bicyclic rings as HSET inhibitors | 默克专利股份公司 | 2025-06-03 | — | — | CN | disclosed |